Featured Research

from universities, journals, and other organizations

Largest Single-institution Study Demonstrates Mammosite Is A Safe Breast Cancer Treatment

Date:
October 18, 2005
Source:
University of Pittsburgh Medical Center
Summary:
Treating breast cancer with MammoSite® resulted in a low risk of complications and was generally well tolerated, according to a University of Pittsburgh study. The study, presented at the 47th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Oct. 16 to 20, also evaluated cosmetic outcome of treatment with MammoSite and found that it was comparable to that of standard external beam radiation.

Related Articles


MammoSite, a type ofbreast brachytherapy (bray-kee-therapy), uses a single catheterinserted into the breast following lumpectomy, or surgical removal of atumor, to deliver a high dose of radiation. Once the catheter isinserted, a tiny balloon is inflated and loaded with radioactive seedsthat deliver prescribed levels of radiation to targeted tissuesurrounding the tumor site.

"MammoSite is a type of partialbreast irradiation that delivers radiation from the inside of thebreast directly to the tumor site where cancer cells are most likely toreside," said Sushil Beriwal, M.D., assistant professor at theUniversity of Pittsburgh School of Medicine and medical director ofradiation oncology at Magee-Womens Hospital of the University ofPittsburgh Medical Center (UPMC). "Ours is one of the largestsingle-institution studies to confirm that it does this safely and withan acceptable level of toxicity."

The study, which was designedto evaluate early outcomes of MammoSite brachytherapy, and was approvedby the FDA in 2002, evaluated toxicity in 100 patients treated betweenJune 2002 and October 2004 at the University of Pittsburgh CancerInstitute. The patients were followed between three and 30 monthssubsequent to treatment with an average follow-up time of one year.After treatment, patients were assessed at one week, one month and atthree-month intervals. While 14 percent of women had to have thecatheter removed because of various reasons, the majority of thepatients (86 percent) underwent treatment.

Post-treatmentcomplications included balloon rupture, infections, skin toxicity andseromas (persistence of the cavity where the lump was removed). Studyresults indicated that balloon rupture occurred in six patients (7percent) and wound infections occurred in 10 patients (12 percent). Nopatients had serious skin toxicities from treatment. A palpable seromawas observed in 34 of the patients (40 percent) and persisted beyondsix months of treatment in 22 patients (26 percent).

The studyalso evaluated cosmetic outcome of MammoSite treatment. Cosmeticoutcome refers to the physical similarity between the treated breastand the untreated breast. Forty-eight patients (56 percent) hadexcellent cosmetic outcomes; 32 patients (37 percent) had good cosmeticoutcomes; and seven patients (7 percent) had fair cosmetic outcomes.

"Ourfindings demonstrate that the toxicities associated with MammoSite weresimilar to results reported in the MammoSite brachytherapy registrytrial," said Dr. Beriwal. "The complications were acceptable and thecosmetic outcome was comparable to what we might see with standardexternal beam radiation." Dr. Beriwal added that follow-up studies willseek to assess the long-term effects as well as the efficacy of thetreatment compared with standard external beam radiation therapy andother types of breast brachytherapy.

###

MammoSite is manufactured by Cytyc Corporation based in Alpharetta, Ga.

Alsoinvolved in the study from the University of Pittsburgh's department ofradiation oncology were Anurag Agarwal, M.D.; Dwight E. Heron, M.D.;Jeffrey Falk, M.D., Ronald Johnson, M.D.; Robert Mogus, R.T.T.; HayeonKim, M.S.; Kristina Gerszten, M.D.; and Melvin Deutsch, M.D.


Story Source:

The above story is based on materials provided by University of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Pittsburgh Medical Center. "Largest Single-institution Study Demonstrates Mammosite Is A Safe Breast Cancer Treatment." ScienceDaily. ScienceDaily, 18 October 2005. <www.sciencedaily.com/releases/2005/10/051018075958.htm>.
University of Pittsburgh Medical Center. (2005, October 18). Largest Single-institution Study Demonstrates Mammosite Is A Safe Breast Cancer Treatment. ScienceDaily. Retrieved January 25, 2015 from www.sciencedaily.com/releases/2005/10/051018075958.htm
University of Pittsburgh Medical Center. "Largest Single-institution Study Demonstrates Mammosite Is A Safe Breast Cancer Treatment." ScienceDaily. www.sciencedaily.com/releases/2005/10/051018075958.htm (accessed January 25, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, January 25, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Mistakes Should Serve a Lesson Says WHO

Ebola Mistakes Should Serve a Lesson Says WHO

AFP (Jan. 25, 2015) — The World Health Organization&apos;s chief on Sunday admitted the UN agency had been caught napping on Ebola, saying it should serve a lesson to avoid similar mistakes in future. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Disneyland Measles Outbreak Spreads To 5 States

Disneyland Measles Outbreak Spreads To 5 States

Newsy (Jan. 24, 2015) — Much of the Disneyland measles outbreak is being blamed on the anti-vaccination movement. The CDC encourages just about everyone get immunized. Video provided by Newsy
Powered by NewsLook.com
Growing Measles Outbreak Worries Calif. Parents

Growing Measles Outbreak Worries Calif. Parents

AP (Jan. 23, 2015) — Public health officials are rushing to contain a measles outbreak that has sickened 70 people across 6 states and Mexico. The AP&apos;s Raquel Maria Dillon has more. (Jan. 23) Video provided by AP
Powered by NewsLook.com
Smart Wristband to Shock Away Bad Habits

Smart Wristband to Shock Away Bad Habits

Reuters - Innovations Video Online (Jan. 23, 2015) — A Boston start-up is developing a wristband they say will help users break bad habits by jolting them with an electric shock. Ben Gruber reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins